PMCID: PMC5574094 Annunen S, Krkk J, Czarny M, Warman ML, Brunner HG, Kriinen H, Mulliken JB, Tranebjaerg L, Brooks DG, Cox GF, Cruysberg JR, Curtis MA, Davenport SL, Friedrich CA, Kaitila I, Krawczynski MR, Latos-Bielenska A, Mukai S, Olsen BR, Shinno N, Somer M, Vikkula M, Zlotogora J, Prockop DJ, Ala-Kokko L
Oral or nasal peptides absorb through the mucosal layer and access your circulation, but injection remains the most reliable delivery system for peptides to reach their intended tissue
Its approved use is to treat HIV-infected patients who suffer from excess abdominal body fat [7]
Standard approach: MK-677: 12.5-25 mg taken orally at night BPC-157: 250-500 mcg administered subcutaneously daily The MK-677 cycle typically extends 8-12 weeks, while BPC-157 runs 4-6 weeks or longer based on healing requirements